226 related articles for article (PubMed ID: 7855957)
1. Percutaneous management of upper-tract transitional cell carcinoma.
Streem SB
Urol Clin North Am; 1995 Feb; 22(1):221-9. PubMed ID: 7855957
[TBL] [Abstract][Full Text] [Related]
2. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
Rouprêt M; Hupertan V; Traxer O; Loison G; Chartier-Kastler E; Conort P; Bitker MO; Gattegno B; Richard F; Cussenot O
Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic treatment of upper tract transitional cell carcinoma.
Soderdahl DW; Fabrizio MD; Rahman NU; Jarrett TW; Bagley DH
Urol Oncol; 2005; 23(2):114-22. PubMed ID: 15869996
[TBL] [Abstract][Full Text] [Related]
4. [Is there a risk of carcinoma dissemination in the percutaneous access for endoscopical treatment of upper urinary tract urothelial tumors?].
Serrano Pascual A; Fernández González I; González-Peramato P; García González R; Lovaco Castellano F
Arch Esp Urol; 2004 Apr; 57(3):283-90. PubMed ID: 15174506
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: the Cleveland Clinic experience.
Gill IS; Sung GT; Hobart MG; Savage SJ; Meraney AM; Schweizer DK; Klein EA; Novick AC
J Urol; 2000 Nov; 164(5):1513-22. PubMed ID: 11025694
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous management of renal pelvic urothelial tumors: long-term followup.
Goel MC; Mahendra V; Roberts JG
J Urol; 2003 Mar; 169(3):925-9; discussion 929-30. PubMed ID: 12576814
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
[TBL] [Abstract][Full Text] [Related]
8. Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma.
Boorjian S; Ng C; Munver R; Palese MA; Vaughan ED; Sosa RE; Del Pizzo JJ; Scherr DS
Urology; 2005 Aug; 66(2):283-7. PubMed ID: 16098357
[TBL] [Abstract][Full Text] [Related]
9. 13-year experience with percutaneous management of upper tract transitional cell carcinoma.
Clark PE; Streem SB; Geisinger MA
J Urol; 1999 Mar; 161(3):772-5; discussion 775-6. PubMed ID: 10022682
[TBL] [Abstract][Full Text] [Related]
10. [Place of laparoscopic nephroureterectomy in the treatment of upper urinary tract transitional cell carcinoma].
Roupret M; Rozet F; Sanderson KM; Lesur G; Almeida D; Harmon JD; Barret E; Cathelineau X; Vallancien G
Prog Urol; 2006 Sep; 16(4):413-7. PubMed ID: 17069031
[TBL] [Abstract][Full Text] [Related]
11. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
Chen GL; Bagley DH
J Urol; 2000 Oct; 164(4):1173-6. PubMed ID: 10992360
[TBL] [Abstract][Full Text] [Related]
12. Nephroureterectomy: rationale in the management of transitional cell carcinoma of the upper urinary tract.
Cummings KB
Urol Clin North Am; 1980 Oct; 7(3):569-78. PubMed ID: 7456169
[TBL] [Abstract][Full Text] [Related]
13. Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience.
Rouprêt M; Hupertan V; Sanderson KM; Harmon JD; Cathelineau X; Barret E; Vallancien G; Rozet F
Urology; 2007 Apr; 69(4):656-61. PubMed ID: 17445646
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis.
Patel A; Soonawalla P; Shepherd SF; Dearnaley DP; Kellett MJ; Woodhouse CR
J Urol; 1996 Mar; 155(3):868-74. PubMed ID: 8583595
[TBL] [Abstract][Full Text] [Related]
15. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma.
Wu CF; Chang PL; Chen CS; Chuang CK; Weng HH; Pang ST
J Urol; 2006 Aug; 176(2):477-81. PubMed ID: 16813872
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma.
Elliott DS; Blute ML; Patterson DE; Bergstralh EJ; Segura JW
Urology; 1996 Jun; 47(6):819-25. PubMed ID: 8677570
[TBL] [Abstract][Full Text] [Related]
17. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma.
Keeley FX; Bibbo M; Bagley DH
J Urol; 1997 May; 157(5):1560-5. PubMed ID: 9112476
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
Urology; 2008 Apr; 71(4):713-7. PubMed ID: 18267338
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract.
Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
Urology; 2005 Feb; 65(2):279-83. PubMed ID: 15708038
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of hand-assisted laparoscopic nephroureterectomy for managing upper urinary tract transitional cell carcinoma--China Medical University Hospital experience.
Chen CH; Wu HC; Chen WC; Yeh CC; Chen CC; Chang CH
Urology; 2005 Apr; 65(4):687-91. PubMed ID: 15833509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
